JoAnn V. Pinkerton

ORCID: 0000-0001-6707-3405 · 7 papers in corpus
other 2023
Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgad209
other 2018
Not time to abandon use of local vaginal hormone therapies
Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000001142

Pinkerton, JoAnn V. MD, FACOG, NCMP; Kaunitz, Andrew M. MD, FACOG, NCMP; Manson, JoAnn E. MD, DrPH, FACP, NCMP

review 2015
Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence
Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000000365

OBJECTIVE: Treatment of menopausal symptoms by compounds with tissue-selective estrogen agonist/antagonist effects, often called selective estrogen receptor modulators, has been researched as an alternative to the use of estrogen therapy. T…

other 2015
Money talks: untreated hot flashes cost women, the workplace, and society
Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000000427

Department of Obstetrics and Gynecology Midlife Health Center University of Virginia Charlottesville, Virginia

review 2011
Pharmacological therapy for abnormal uterine bleeding
Menopause (New York, N.Y.) ·doi:10.1097/gme.0b013e318212499c

Pharmacological therapies for the treatment of abnormal uterine bleeding are effective and generally well tolerated. This review presents an evidence-based approach to medical therapy. Selection depends on the etiology and amount of bleedin…

2010
Endometriosis
·doi:10.1210/jcem.95.12.9999

pblico para promover la prevencin, tratamiento y cura de trastornos hormonales.Se permite la reproduccin de esta pgina para fines no comerciales por profesionales e instructores mdicos que deseen compartirla con sus pacientes y estudiantes.

2010
Endometriosis
·doi:10.1210/jcem.95.12.9998